US Patent 11530400 Process and system for obtaining botulinum neurotoxin
Patent 11530400 was granted and assigned to Allergan, Inc. on December, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Hemant A. Patel0
Jennifer L. Ton0
Ronald C. Bates0
Wajdie M. Ahmad0
Edits on 26 Mar, 2023
Golden AI
Infobox
Edits on 22 Mar, 2023
Golden AI
Infobox
Edits on 21 Dec, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+169 characters)
US Patent 11530400 Process and system for obtaining botulinum neurotoxin
Article
Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115304000
Date of Patent
December 20, 2022
0Patent Application Number
178355030
Date Filed
June 8, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11530400 Process and system for obtaining botulinum neurotoxin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.